CONTRACT LABORATORY . COM
For information, please call Toll-Free 1-877-353-0451 or email us
Find Laboratories for All your Laboratory Testing & Scientific Research !
Home
Laboratory Directories
Laboratory Careers
Laboratory Events
Laboratory Resources
Laboratory News
Accounts
Submit Lab Requests
Browse Lab Test Requests
Lab Directories
Lab Service Requests
Lab Product Requests

Lab Business Opportunities

About Us
Laboratory Test Requests
Laboratory Registration

Find independent contract albroatories for all your laboratory testing and scientific research and development such as microbiology laboratories, preclinical laboratories, virology laboratories, product safety laboratories, analytical chemistry laboratories, materials laboratories, electrical laboratories, physical laboratories, biotechnology laboratories, biomechanical laboratories, etc. Laboratory News

SCIENTIFIC IMAGE CREDIT: Dr. Janice Haney Carr, US Centers for Disease Control and Prevention (CDC). This colorized scanning electron micrograph (SEM) reveals a small clustered group of Gram-positive, beta-hemolytic Group C Streptococcus sp. bacteria.

25 Most Recent Submitted Laboratory News
Submit Laboratory News and Press Releases Here

The deadline for applications to participate in the UKAS programme for the accreditation of certification bodies to certify Green Deal Advisors and Installers expired on 30 September 2011. UKAS received 33 applications from organisations who wish to participate in the pilot programme and all 33 applicants will have the opportunity to be assessed over the next 10 months. The assessments will be carried out in two stages, with a pilot group of 20 applicants commencing their assessments immediately and the remaining 13 applicants commencing their assessments in a second stage programme from Ap UKAS Assessment Programme for Accreditation for Certification of Green Deal Advisors and Installers
2011-12-12 00:00:00,
The deadline for applications to participate in the UKAS programme for the accreditation of certification bodies to certify Green Deal Advisors and Installers expired on 30 September 2011. UKAS received 33 applications from organisations who wish to participate in the pilot programme and all 33 applicants will have the opportunity to be assessed over the next 10 months. The assessments will be carried out in two stages, with a pilot group of 20 applicants commencing their assessments immediat( read more).....
The Therapeutic Goods Administration (TGA) advises that certain lots of the Trident Catheter Valve (Australian Register of Therapeutic Goods (ARTG) number 107139) are being recalled. The Trident Catheter Valve is used for connecting a urinary catheter to an overnight drainage bag. It gives users the opportunity to retrain the bladder and reduce the reliance on urine bags. The recall is being conducted because a routine sterility test on the Trident Catheter Valve in a particular set of lots has failed. This raised concerns that the valves in these lots may not be sterile. To date, no Trident catheter valve - Model Number: 380851
2011-12-12 00:00:00,
The Therapeutic Goods Administration (TGA) advises that certain lots of the Trident Catheter Valve (Australian Register of Therapeutic Goods (ARTG) number 107139) are being recalled. The Trident Catheter Valve is used for connecting a urinary catheter to an overnight drainage bag. It gives users the opportunity to retrain the bladder and reduce the reliance on urine bags. The recall is being conducted because a routine sterility test on the Trident Catheter Valve in a particular set of lot( read more).....
Government to improve regulation of therapeutic goods media release, The Hon Catherine King MP 8 December 2011 The Australian Government has released its response to several major reviews of therapeutic goods regulation that have been undertaken over the past 18 months. These reviews include: the review to improve the transparency of the public consultations on the regulatory framework for advertising therapeutic goods the Auditor-General's report on Therapeutic Goods Regulation: Complementary Medicines an informal working group examining the regulation of complementa TGA reforms: a blueprint for TGA's future
2011-12-08 00:00:00,
Government to improve regulation of therapeutic goods media release, The Hon Catherine King MP 8 December 2011 The Australian Government has released its response to several major reviews of therapeutic goods regulation that have been undertaken over the past 18 months. These reviews include: the review to improve the transparency of the public consultations on the regulatory framework for advertising therapeutic goods the Auditor-General's report on Therapeutic Goods Regu( read more).....
After 10 years of diverse bioenvironmental research and testing, RespirTek has obtained ISO 17025 Certification and is continuing to improve upon the strong foundations of excellent customer service and quality testing that has served our clients well over the years. RespirTek remains committed to these foundational objectives that have led us to continually impact the scientific, engineering, and product development communities. We are pleased to announce the following improvements to our organization:  ISO 17025 Certification for Continued Excellence in Test Execution and Quality Cont Respirtek ISO 17025 Business Management Improvements
2011-11-22 00:00:00,
After 10 years of diverse bioenvironmental research and testing, RespirTek has obtained ISO 17025 Certification and is continuing to improve upon the strong foundations of excellent customer service and quality testing that has served our clients well over the years. RespirTek remains committed to these foundational objectives that have led us to continually impact the scientific, engineering, and product development communities. We are pleased to announce the following improvements to our orga( read more).....
After 10 years of diverse bioenvironmental research and testing, RespirTek has obtained ISO 17025 Certification and is continuing to improve upon the strong foundations of excellent customer service and quality testing that has served our clients well over the years. RespirTek remains committed to these foundational objectives that have led us to continually impact the scientific, engineering, and product development communities. We are pleased to announce the following improvements to our organization:  ISO 17025 Certification for Continued Excellence in Test Execution and Quality Cont Respirtek, Inc. ISO 17025 Accreditation Announcement
2011-11-22 00:00:00,
After 10 years of diverse bioenvironmental research and testing, RespirTek has obtained ISO 17025 Certification and is continuing to improve upon the strong foundations of excellent customer service and quality testing that has served our clients well over the years. RespirTek remains committed to these foundational objectives that have led us to continually impact the scientific, engineering, and product development communities. We are pleased to announce the following improvements to our orga( read more).....
The first pilot assessment by UKAS of an inspection body involved in inspection of fairground and amusement park devices is now under way. A pre- assessment of Jacobs Engineering (UK) Ltd, Ashton Lane, Manchester was conducted by UKAS recently, where Jacobs' readiness to proceed to the initial assessment stage was established and an action plan was agreed. At the initial assessment, UKAS will establish the inspection body's compliance with the international standard ISO/IEC 17020, Generic criteria for the operation of various types of bodies performing inspection, and its competence to per UKAS Accreditation for Inspection of Fairground and Amusement Park Devices - Pilot Project Update
2011-11-11 00:00:00,
The first pilot assessment by UKAS of an inspection body involved in inspection of fairground and amusement park devices is now under way. A pre- assessment of Jacobs Engineering (UK) Ltd, Ashton Lane, Manchester was conducted by UKAS recently, where Jacobs' readiness to proceed to the initial assessment stage was established and an action plan was agreed. At the initial assessment, UKAS will establish the inspection body's compliance with the international standard ISO/IEC 17020, Generic cr( read more).....
A new edition of Accreditation Matters, UKAS' newsletter for the public sector, has been released. Issue 8 gives information about the appointment of UKAS as the accreditation body for the Green Deal, the Government's flagship programme for improving the energy efficiency of British properties, new accreditation activity in support of plant health inspections, crime scene investigations and telecommunications services, as well as general background on UKAS and accreditation. Accreditation Matters continues to be an effective means of increasing the level of knowledge of accreditation acro ACCREDITATION MATTERS ISSUE 8 NOW AVAILABLE
2011-11-08 00:00:00,
A new edition of Accreditation Matters, UKAS' newsletter for the public sector, has been released. Issue 8 gives information about the appointment of UKAS as the accreditation body for the Green Deal, the Government's flagship programme for improving the energy efficiency of British properties, new accreditation activity in support of plant health inspections, crime scene investigations and telecommunications services, as well as general background on UKAS and accreditation. Accreditation M( read more).....
Radiopharmaceutical sterility testing is required during the sterilization validation process as well as for routine product release testing. USP <71> sterility testing is an official test to determine sterility of a product. Nova's understanding of USP <71> is important to the radiopharmaceutical industry because it allows us to assist in designing a sterility test validation process. USP <71> testing of radiopharmaceuticals is a scientifically complex process that must be performed by trained and qualified radiological and microbiological laboratory personnel. Nova's highly qualified and exp Nova now provides Sterility and Endotoxin Testing for the Radiopharmaceutical Industry
2011-11-01 00:00:00,
Radiopharmaceutical sterility testing is required during the sterilization validation process as well as for routine product release testing. USP <71> sterility testing is an official test to determine sterility of a product. Nova's understanding of USP <71> is important to the radiopharmaceutical industry because it allows us to assist in designing a sterility test validation process. USP <71> testing of radiopharmaceuticals is a scientifically complex process that must be performed by trained ( read more).....
The U.S. Food and Drug Administration today announced the award of $2 million to support two regional Centers of Excellence in Regulatory Science and Innovation (CERSI). The centers, which will be located at the University of Maryland and Georgetown University, will focus on strengthening science and training needed to modernize and improve the ways drugs and medical devices are reviewed and evaluated, a major focus within the FDA. In August 2011, the agency released the strategic plan for: FDA invests $2 million in partnerships through Centers of Excellence in Regulatory Science and Innovation
2011-10-26 00:00:00,
The U.S. Food and Drug Administration today announced the award of $2 million to support two regional Centers of Excellence in Regulatory Science and Innovation (CERSI). The centers, which will be located at the University of Maryland and Georgetown University, will focus on strengthening science and training needed to modernize and improve the ways drugs and medical devices are reviewed and evaluated, a major focus within the FDA. In August 2011, the agency released the strategic plan for( read more).....
FDA approves first generic olanzapine to treat schizophrenia, bipolar disorder The U.S. Food and Drug Administration today approved the first generic versions of Zyprexa (olanzapine tablets) and Zyprexa Zydus (olanzapine orally disintegrating tablets) to treat schizophrenia and bipolar disorder. Schizophrenia is a chronic, severe, and disabling brain disorder. About 1 percent of Americans have this illness. Symptoms people with schizophrenia have include: hearing voices, believing other people are reading their minds or controlling thoughts, and being suspicious or withdrawn. Bipolar
2011-10-26 00:00:00,
FDA approves first generic olanzapine to treat schizophrenia, bipolar disorder The U.S. Food and Drug Administration today approved the first generic versions of Zyprexa (olanzapine tablets) and Zyprexa Zydus (olanzapine orally disintegrating tablets) to treat schizophrenia and bipolar disorder. Schizophrenia is a chronic, severe, and disabling brain disorder. About 1 percent of Americans have this illness. Symptoms people with schizophrenia have include: hearing voices, believing other pe( read more).....
On Oct. 21, the U.S. Food and Drug Administration approved Onfi tablets (clobazam) for use as an adjunctive (add-on) treatment for seizures associated with Lennox-Gastaut syndrome in adults and children 2 years of age and older. As Onfi is intended to treat a disease or condition that affects fewer than 200,000 people in the United States, it was granted orphan drug designation by the FDA. FDA approves Onfi to treat severe type of seizures
2011-10-26 00:00:00,
On Oct. 21, the U.S. Food and Drug Administration approved Onfi tablets (clobazam) for use as an adjunctive (add-on) treatment for seizures associated with Lennox-Gastaut syndrome in adults and children 2 years of age and older. As Onfi is intended to treat a disease or condition that affects fewer than 200,000 people in the United States, it was granted orphan drug designation by the FDA. "Lennox-Gastaut syndrome is a severe form of epilepsy that causes debilitating seizures," said Russell K( read more).....
FDA: U.S. Marshals seize food products at U.S. Marshals, acting at the request of the FDA, seized various food products stored in a warehouse owned by Chetak Chicago LLC, in Streamwood, Ill., on October 17, 2011. The products were seized under a warrant issued by the U.S. District Court for the Northern District of Illinois. The FDA initiated the seizure after finding extensive evidence of unsanitary conditions throughout the warehouse during a recent inspection. Investigators collected more than 300 samples of materials showing significant unsanitary conditions, in violation of the Federal Illinois warehouse Prevents unsafe food distribution from rodent-infested facility
2011-10-19 00:00:00,
FDA: U.S. Marshals seize food products at U.S. Marshals, acting at the request of the FDA, seized various food products stored in a warehouse owned by Chetak Chicago LLC, in Streamwood, Ill., on October 17, 2011. The products were seized under a warrant issued by the U.S. District Court for the Northern District of Illinois. The FDA initiated the seizure after finding extensive evidence of unsanitary conditions throughout the warehouse during a recent inspection. Investigators collected more ( read more).....
The U.S. Food and Drug Administration has issued a proposed rule and draft special controls guidance lowering the risk classification for external pacemaker pulse generators from Class III (high-risk) to Class II (moderate-risk). External pacemaker pulse generators are used temporarily to regulate a patient's heartbeat until a permanent pacemaker can be implanted. They are also used following heart surgery or after a heart attack to control irregular heartbeats. FDA proposes lower risk classification, special controls for external pacemakers Classification of "preamendment" device clarifies FDA review process
2011-10-19 00:00:00,
The U.S. Food and Drug Administration has issued a proposed rule and draft special controls guidance lowering the risk classification for external pacemaker pulse generators from Class III (high-risk) to Class II (moderate-risk). External pacemaker pulse generators are used temporarily to regulate a patient's heartbeat until a permanent pacemaker can be implanted. They are also used following heart surgery or after a heart attack to control irregular heartbeats. "The FDA has assessed ( read more).....
The U.S. Food and Drug Administration today approved Ferriprox (deferiprone) to treat patients with iron overload due to blood transfusions in patients with thalassemia, a genetic blood disorder that causes anemia, who had an inadequate response to prior chelation therapy. Patients with thalassemia have excess iron in the body from the frequent blood transfusions (transfusional iron overload), a condition that is serious and can be fatal. These patients also have a risk of developing liver disease, diabetes, arthritis, heart failure or an abnormal heart rhythm. The standard of care to t FDA approves Ferriprox to treat patients with excess iron in the body
2011-10-19 00:00:00,
The U.S. Food and Drug Administration today approved Ferriprox (deferiprone) to treat patients with iron overload due to blood transfusions in patients with thalassemia, a genetic blood disorder that causes anemia, who had an inadequate response to prior chelation therapy. Patients with thalassemia have excess iron in the body from the frequent blood transfusions (transfusional iron overload), a condition that is serious and can be fatal. These patients also have a risk of developing liver di( read more).....
At the request of the U.S. Food and Drug Administration, U.S. Marshals seized food products held at the food storage and processing facility of Dominguez Foods of Washington, Inc., in Zillah, Wash., on Sept. 30, 2011. The seized products had been subject to a detention order issued by FDA on Sept. 2, 2011, following an FDA inspection of the facility that found evidence of widespread and active rodent and insect infestation in the facility's warehouse and processing area. In a complaint filed Sept. 29, 2011, the United States alleged that the detained food was adulterated under the Federa FDA: U.S. Marshals seize foods stored at Washington State facility FDA inspection found rodent and insect infestation
2011-10-11 00:00:00,
At the request of the U.S. Food and Drug Administration, U.S. Marshals seized food products held at the food storage and processing facility of Dominguez Foods of Washington, Inc., in Zillah, Wash., on Sept. 30, 2011. The seized products had been subject to a detention order issued by FDA on Sept. 2, 2011, following an FDA inspection of the facility that found evidence of widespread and active rodent and insect infestation in the facility's warehouse and processing area. In a complaint fil( read more).....
The U.S. Food and Drug Administration and the Centers for Medicare & Medicaid Services (CMS) today launched a FDA, CMS launch pilot program for voluntary parallel review of innovative devices Aim is to reduce time between FDA approval and CMS national coverage determinations
2011-10-07 00:00:00,
The U.S. Food and Drug Administration and the Centers for Medicare & Medicaid Services (CMS) today launched a "parallel review" pilot program for concurrent review of medical devices for FDA approval and Medicare coverage. The FDA and CMS, which will begin accepting submissions today, issued procedures for voluntary participation and guiding principles that the agencies will follow during product review. The FDA and CMS anticipate that parallel review will facilitate the development of innova( read more).....
The U.S. Food and Drug Administration today approved Cialis (tadalafil) to treat the signs and symptoms of benign prostatic hyperplasia (BPH), a condition in which the prostate gland becomes enlarged, and for the treatment of BPH and erectile dysfunction (ED), when the conditions occur simultaneously. Cialis was approved in 2003 for the treatment of ED. Common symptoms of BPH include difficulty in starting urination and a weak urine stream; a sudden urge to urinate; and more frequent urination including at night. The severity of symptoms of BPH can be measured using the International Pro FDA approves Cialis to treat benign prostatic hyperplasia
2011-10-06 00:00:00,
The U.S. Food and Drug Administration today approved Cialis (tadalafil) to treat the signs and symptoms of benign prostatic hyperplasia (BPH), a condition in which the prostate gland becomes enlarged, and for the treatment of BPH and erectile dysfunction (ED), when the conditions occur simultaneously. Cialis was approved in 2003 for the treatment of ED. Common symptoms of BPH include difficulty in starting urination and a weak urine stream; a sudden urge to urinate; and more frequent urinatio( read more).....
The U.S. Food and Drug Administration and the National Institutes of Health today announced a joint, large-scale, national study of tobacco users to monitor and assess the behavioral and health impacts of new government tobacco regulations. The initiative, called the Tobacco Control Act National Longitudinal Study of Tobacco Users, is the first large-scale NIH/FDA collaboration on tobacco regulatory research since Congress granted FDA the authority to regulate tobacco products in the Family Smoking Prevention and Tobacco Control Act of 2009. Scientific experts at NIH's National Institute FDA and NIH announce joint study on tobacco use and risk perceptions Landmark collaboration is the first since the passing of the 2009 Tobacco Control Act
2011-10-06 00:00:00,
The U.S. Food and Drug Administration and the National Institutes of Health today announced a joint, large-scale, national study of tobacco users to monitor and assess the behavioral and health impacts of new government tobacco regulations. The initiative, called the Tobacco Control Act National Longitudinal Study of Tobacco Users, is the first large-scale NIH/FDA collaboration on tobacco regulatory research since Congress granted FDA the authority to regulate tobacco products in the Family S( read more).....
FDA Commissioner Margaret A. Hamburg, M.D., today released a blueprint containing immediate steps that can be taken to drive biomedical innovation, while improving the health of Americans. Titled FDA commissioner outlines steps to spur biomedical innovation, improve health of Americans
2011-10-05 00:00:00,
FDA Commissioner Margaret A. Hamburg, M.D., today released a blueprint containing immediate steps that can be taken to drive biomedical innovation, while improving the health of Americans. Titled "Driving Biomedical Innovation: Initiatives for Improving Products for Patients,"the blueprint addresses concerns about the sustainability of the medical product development pipeline, which is slowing down despite record investments in research and development. "The Obama Administration is commi( read more).....
FDA's Center for Devices and Radiological Health (CDRH) is soliciting comment on a plan to create a network of outside scientific experts who would provide staff with rapid access to specific specialized knowledge about emerging technology, as well as other topics. To further enrich this comment period, CDRH will also conduct a 12-week pilot of the network through Dec. 30, 2011. CDRH has a world-class scientific staff that includes scientists, engineers, and clinicians. Nevertheless, there are times when staff must turn to external sources to further enhance their scientific understanding, FDA outlines plans for an outside network of scientific experts Network will help quickly address regulatory concerns, broaden staff knowledge of new and emerging technologies
2011-10-04 00:00:00,
FDA's Center for Devices and Radiological Health (CDRH) is soliciting comment on a plan to create a network of outside scientific experts who would provide staff with rapid access to specific specialized knowledge about emerging technology, as well as other topics. To further enrich this comment period, CDRH will also conduct a 12-week pilot of the network through Dec. 30, 2011. CDRH has a world-class scientific staff that includes scientists, engineers, and clinicians. Nevertheless, there ar( read more).....
The U.S. Food and Drug Administration today announced the awards of three grants to boost the development and availability of medical devices for children. A panel of five experts with experience in medicine, business, and device development reviewed 10 applications for the grants, which will be administered by the FDA's Office of Orphan Products Development. The recipients and grant amounts include:  James Geiger, M.D. and Andre Muelenaer, M.D. of the University of Michigan Pediatric Device Consortium and the Pediatric Medical Device Institute Pediatric Medical Device Consortium, $1.1 FDA awards three grants to stimulate development of pediatric medical devices Grantees will work with industry and the FDA to address unmet pediatric device needs
2011-10-03 00:00:00,
The U.S. Food and Drug Administration today announced the awards of three grants to boost the development and availability of medical devices for children. A panel of five experts with experience in medicine, business, and device development reviewed 10 applications for the grants, which will be administered by the FDA's Office of Orphan Products Development. The recipients and grant amounts include:  James Geiger, M.D. and Andre Muelenaer, M.D. of the University of Michigan Pediatric Dev( read more).....
The U.S. Food and Drug Administration's Center for Devices and Radiological Health (CDRH) today released a report highlighting scientific activities that support the medical device industry and product development, while maintaining the safety and effectiveness of the products. The report, FDA works to improve science used to approve medical devices
2011-10-03 00:00:00,
The U.S. Food and Drug Administration's Center for Devices and Radiological Health (CDRH) today released a report highlighting scientific activities that support the medical device industry and product development, while maintaining the safety and effectiveness of the products. The report, "Regulatory Science in FDA's Center for Devices and Radiological Health: A Vital Framework for Protecting and Promoting Public Health," offers a look at the work FDA engages in every day to help foster sci( read more).....
READING, PENNSYLVANIA, USA, October 3, 2011 - Poplar Solutions, LLC, a leader in web-based document and records management solutions for life science companies and analytical laboratories announced that the U.S. EPA Region 6 Environmental Services Branch (ESB) Laboratory, located in Houston, Texas has chosen to implement its Labcore Scientific Data Management System (SDMS) to automate its laboratory operations including data package assembly and management. The Environmental Services Branch (ESB) Laboratory serves a critical role in scientific support for Regional Quality Assurance efforts. EPA Purchases Labcore to Improve Laboratory Efficiency, Reduce Paper and Quickly Assemble Data Packages
2011-10-03 00:00:00,
READING, PENNSYLVANIA, USA, October 3, 2011 - Poplar Solutions, LLC, a leader in web-based document and records management solutions for life science companies and analytical laboratories announced that the U.S. EPA Region 6 Environmental Services Branch (ESB) Laboratory, located in Houston, Texas has chosen to implement its Labcore Scientific Data Management System (SDMS) to automate its laboratory operations including data package assembly and management. The Environmental Services Branch (( read more).....
Water quality and environmental health in Botswana; wetlands in a working landscape; the collapse of the ancient Maya and what that has to tell us about society and environmental change today. These and other projects that address how humans and the environment interact are the focus of $21 million in National Science Foundation (NSF) grants to scientists, engineers and educators across the country to study coupled natural and human systems. Research conducted through NSF's Dynamics of Coupled Natural and Human Systems (CNH) program, in its fifth year as a multi-directorate program, will New Understanding of How Humans and the Environment Interact National Science Foundation Grants Awarded for Research on Coupled Natural and Human Systems
2011-09-21 00:00:00,
Water quality and environmental health in Botswana; wetlands in a working landscape; the collapse of the ancient Maya and what that has to tell us about society and environmental change today. These and other projects that address how humans and the environment interact are the focus of $21 million in National Science Foundation (NSF) grants to scientists, engineers and educators across the country to study coupled natural and human systems. Research conducted through NSF's Dynamics of Cou( read more).....
Molecular structure of retrovirus enzyme solved through On-line Gamers Succeed Where Scientists Fail, Opening Door to New AIDS Drug Design
2011-09-21 00:00:00,
Molecular structure of retrovirus enzyme solved through "Foldit" Online gamers have solved the structure of a retrovirus enzyme whose configuration had stymied scientists. The players were adept at a computer game, Foldit, that allows players to collaborate and compete in predicting the structure of protein molecules. After scientists repeatedly failed to piece together the structure of a protein-cutting enzyme from an AIDS-like virus, they called in the Foldit players. The scientists ( read more).....

 

(ADVERTISE HERE!) Advertising, sponsorship or media partnerships are available. Please contact us 403-770-1992 at email us

Contract Laboratory .com can assist your company in finding Contract Laboratories or Contract Research Organizations to perform other scientific research, laboratory testing, surveys, reverse engineering, investigations, inspections, certifications, arrays, analysis, quality control, examinations, field studies, engineering, sampling, observations, assays, experimentation or research studies in such areas as:
 

Laboratory Testing Requests

Fulfill your Lab Testing and Scientific Research Requirements! Save Time Searching and Find the Labs to perform all your Lab Testing and Scientific Research at No Charge !
Submit Lab Testing Requests

Increase your contract research and contract laboratory business and find new clients with our Lab Test and Scientific Research and Development Requests
View Lab Testing Requests

Laboratory Service Requests

Need laboratory services such as laboratory consulting, medicinal chemistry, formulation, chemical processing, methods development, scientific methods validation, cleaning validation, experimental design, pharmaceutical formulation, grant writing, cell banking, drug development, laboratory design, laboratory construction or laboratory renovation, LIMS validation, instrument calibration, environmental monitoring, genetic mapping, reverse engineering, deformulation, technology commercialization, scientific modeling, prototyping, exerimental studies, remediation, waste management, industrial hygiene, expert witness, industrial design, production, chemical manufacturing, biomanuacturing, intellectual property, regulatory consulting, validation consulting, language translation, scientiic reviews, executive recruiting, automation, protein synthesis, DNA extraction, DNA cloning, sterilization, research studies, environmental monitoring, scientific reviews, chemical synthesis, manufacturing, technical translations, HVAC systems, product development, product design, informatics, cheminformatics, bioinformatics, statistics, computational chemsitry, statistical reviews, water systems, chemical engineering, biosafety, , SOP Quality Systems, GMP, GLP, GCP, ISO audits, USP, AAALAC, ISO, GLP, ICH, AOAC, ASTM, CLIA, A2LA, UKAS training, certification, inspections, surveys, engineering, technology transfer, ? Find scientific consultants, laboratory consultants, scientists, metrology laboratories, service providers. Submit your Service Requests at no charge!
Submit Laboratory Services Requests

Scientific Consultants, Laboratory Consultants, Laboratory Service Providers find new contracts, increase your business & promote your services!> View Laboratory Service Requests

Laboratory and Science Business Opportunities

Want new Science, Laboratory or Technology Business Opportunities such as Laboratory Acquisitions, Laboratory Mergers, Scientiic Licensing or Technology Licensing, In-Licensing, Scientific Collaborations, Co-Marketing, Scientiic Partnerships, Laboratory Expansions, Laboratory Equipment Financing or Scientific Funding, Scientific Equipment Leasing, Scientific Instrument Distributions, Science Co-Developments ? Submit your Laboratory Business Opportunities
Submit Lab Business Opportunities

Expand your Science, Laboratory or Technology Business Business ! Find New Business Opportunities!
View Business Opportunities

Laboratory Product Requests

Need laboratory or scientific equipment, scientific instruments, such as scientific controls, stem cells, cell lines, oligonucleotides, assays, chromatography supplies, titrators, NMR, elemental analyzers, HPLC, autosamplers, DNA synthesizers, fermentors, autoclaves, standards, water filtration, water purification systems, mass spectrometer, LIMS software, polarographic analyzers, face masks, sterilie products, surgical masks, environmental chambers, laboratory robotics, analyzers, scientiic publications, scientific assays, bioassays, microarrays, scientific instruments, flow injection analyzers, robotics, software, automation, hybridomas, cell cultures, controls, microarrays, arrays, furniture, fume hoods, incubators, microscopes, spectrophotometers, bioreactors, centrifuges, biosafety cabinets, HPLC, GC/MS, monitoring systems, sterilizers, biohazard safety cabinets, isolators, PCR, cytometers, biosensors, lyophilizers, ELISA, LIMS software, automation systems,?
Submit laboratory Product Requests

Scientific Suppliers and Laboratory Suppliers increase your sales & promote your laboratory products !
 View Laboratory and Scientific Product Requests

About Us
Contact Us
Partners
Advertise with Us
Statistics & Demographics
Investors
Employment
Site Map
Contract Laboratory .com values your privacy. For more information on our Privacy Policy, please visit Privacy Policy
DISCLAIMER: This information is provided as a service only. Company and product information is prepared by individual companies and has not been independently verified. As such Contract Laboratory Inc can not be responsible for any loss or damage arising from the purchase, sale or use of any service or product through this site.

This site is owned and managed by Contract Laboratory, Inc.